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Abstract
Background: Autosomal dominant Holt-Oram syndrome (HOS) is caused by mutations in the
TBX5 gene and is characterized by congenital heart and preaxial radial ray upper limb defects. Most
of the TBX5 mutations found in patients with HOS cause premature truncation of the primary
TBX5 transcript. TBX5 missense mutations alter the three-dimensional structure of the protein and
result in failed nuclear localization or reduced binding to target DNA. In this study we present our
functional analyses of the novel and unusual c.1333delC mutation found in a patient with classical
HOS.
Methods:  The functional impact of this novel mutation was assessed by investigating the
intracellular localization of the resulting TBX5 protein and its ability to activate the expression of
its downstream target ANF.
Results: The deletion of the cytosine is the first TBX5 frameshift mutation predicted to result in
an elongated TBX5 protein with 74 miscoding amino acids and 62 supernumerary C-terminal
amino acids. The c.1333delC mutation affects neither the nuclear localization, nor its colocalization
with SALL4, but severely affects the activation of the ANF promoter.
Conclusion: The mutation c.1333delC does not locate within functional domains, but impairs the
activation of the downstream target. This suggests that misfolding of the protein prevents its
biological function.
Background
Holt-Oram syndrome (HOS) is an autosomal-domi-
nantly inherited disorder caused by mutations in the gene
coding for the T-box transcription factor TBX5, which is
located on chromosome 12q24 [1,2]. Clinical features are
highly penetrant congenital skeletal malformations of the
upper limbs associated with variable cardiac anomalies
including ASD, VSD, AVSD, PDA, tetralogy of Fallot, heart
conduction failure and pulmonary vein anomalies [3]. To
date, more than 60 different germline TBX5 gene muta-
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tions have been described (TBX5 gene mutation database;
http://www.uni-leipzig.de/~genetik/TBX5) [4]. A vast
majority of these mutations (nonsense, frameshift and
splice site mutations) result in preterminal stop codons
leading to truncated nonfunctional proteins. Also larger
deletions spanning one or more exons have been reported
[5,6]. Nonsyndromic germline mutations are not known
[7], but somatic mutations (exclusively missense muta-
tions) were found in non-HOS related malformed hearts
[8]. The detection rate of mutations in the TBX5 gene in
patients with familial or sporadic HOS is 74% following
application of stringent clinical criteria [9].
TBX5 contains a T-box motif involved in DNA-binding
and protein-protein interactions, and operates as a tran-
scriptional activator [10,11]. Mutations within the T-box
affect DNA-binding and interaction with NKX2-5, result-
ing in reduced activation of downstream targets in the car-
diac conduction system development [12,13]. In the
mouse, Tbx5 controls Fgf10  expression in a synergistic
manner together with Sall4 in the forelimbs via direct
effects on the Fgf10  promoter [14]. This cooperative
action of Tbx5 and Sall4 can be counteracted by Tbx2 and
Tbx3. Furthermore, TBX5 was shown to interact with
GATA4. Specific missense mutations within TBX5 abro-
gate this interaction and cause cardiac septal defects [15].
Transactivation of TBX5 is promoted by TAZ, a protein
complexing TBX5 and interacting with the histone acetyl-
transferase p300 [16]. During embryogenesis TBX5 local-
izes to cellular nuclei. The protein transport is mediated
by two distinct, evolutionary conserved nuclear localiza-
tion signals (NLS) acting cooperatively [17]. Missense
mutations within these conserved sequences impair
nuclear localization and cause "functional" haploinsuffi-
ciency due to decreased protein concentration at the loca-
tion of its biological function [13].
Here we report on the results of functional analyses of a de
novo  c.1333delC mutation identified in a patient with
sporadic HOS. This mutation does not impair nuclear
localization or co-localization with SALL4, but abrogates
activation of the ANF promoter.
Methods
Case report
The now 4-year old male patient (Fig. 1) presented with
typical manifestations of Holt-Oram syndrome: bilateral
hypoplastic clavicles and radii (Fig. 1A, 1C), bilateral
triphalangeal thumbs (Fig. 1B), total ASD and muscular
VSD, bradycardia due to atrioventricular block requiring
pacemaker, hypoplastic lung and pulmonary veins on the
right side. He also had micrognathia and a long philtrum.
Mental development is normal up to now.
Genetic analysis
After obtaining informed consent, genomic DNA was
extracted from peripheral blood lymphocytes of the index
patient and his unaffected parents according to standard
protocols. Mutation analysis of the coding sequence of the
TBX5  gene including exon-intron boundaries was per-
formed by direct DNA sequencing as described [18].
Plasmids
TBX5 expression constructs were generated by PCR ampli-
fication using the commercially available human full-
length cDNA clone (IRATp970D0542D, RZPD, Berlin,
Germany). The sequence of the constructs was verified by
automated sequencing (ABI Prism® 3100 Genetic Ana-
lyzer, Applied Biosystems, Darmstadt, Germany). PCR
fragments were subcloned into the pGEM®-T-Easy vector
(Promega, Madison, WI, USA), digested with EcoRI and
BamHI and subsequently cloned into the pEGFP-N3/
pFLAG-N3 vectors (BD Biosciences, Mountain View, CA,
USA). The ANF-luciferase vector was a kind gift from
Benoit Bruneau (Hospital for Sick Children, Toronto,
Canada).
Generation of the c.1333delC mutation
The TBX5 construct carrying the c.1333delC mutation was
generated with the QuikChange™ Site-directed Mutagene-
sis kit (Stratagene, La Jolla, CA, USA). Successful incorpo-
ration of the mutations was confirmed by automated
sequencing.
Cell culture
COS-7 cells were grown in Minimal essential Medium
(MEM), 10% Fetal Calf Serum, 100 μg/ml penicillin, 100
μg/ml streptomycin, 1× MEM nonessential amino acids
(all purchased from Invitrogen, Carlsbad, CA, USA) and
maintained in a humidified environment with 5% carbon
dioxide.
Intracellular localization
Co-transfected COS-7 cells were directly seeded on glass
coverslips in 24-well plates (1 × 104  cells per plate),
washed in PBS after 24 h, fixed with methanol, washed in
PBS and blocked for 30 min in 0.5% BSA in IF buffer (10
mM Tris pH 7.5, 300 mM NaCl, 0.05% (v/v) Tween 20).
For the detection of intracellular SALL4 localization, cov-
erslips were incubated with a monoclonal anti-FLAG® M2
antibody (Stratagene, La Jolla, CA, USA) for 1 h, washed
twice with IF buffer and incubated with a fluorescence-
labeled anti-mouse IgG (Fab specific)-TRITC antibody for
30 min. Cells were washed three times with IF buffer and
mounted on slides with aquamount (BDH Laboratories,
Poole, UK). Where indicated, cell nuclei were stained with
DAPI blue. The TBX5 distribution pattern could be visual-
ized due to fluorescence of the GFP fusion protein. CellsBMC Medical Genetics 2008, 9:88 http://www.biomedcentral.com/1471-2350/9/88
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were analyzed by confocal laser scanning microscopy
(CLSM).
Reporter gene assays
The wild type and mutated TBX5 cDNAs were cloned into
the mammalian expression vector pFLAG-N3. The
reporter construct contained the luciferase gene under the
control of the atrial natriuretic factor (ANF) promoter.
Each transfection was performed at least in triplicate in
24-well plates and all assays were done with two different
DNA preparations of each construct. Transfections of
adherent COS-7 cells were carried out at 60–80% conflu-
ency using 1 μg Lipofectamine™2000 reagent (Invitrogen,
Carlsbad, CA, USA) per 500 ng transfected DNA. In each
transfection an equimolar DNA concentration was used.
Control vector pRL-SV40 (Promega, Madison, WI, USA),
expressing the Renilla reniformis luciferase, was co-trans-
fected for relativating transfection efficiency at a ratio of
1:100 to the total amount of transfected DNA. In order to
analyze the transcriptional regulation capability of the
TBX5 constructs, 300 ng ANF-luciferase plasmid and 300
ng TBX5 expression vector were used for co-transfections.
DNAs of empty expression vector plasmids were used as
negative control. Cell extracts were harvested 24 hours
after transfection and dissolved in 125 μl Passive Lysis
Buffer (Promega) per well. 20 μl were used to measure
luciferase activity according to the Dual Luciferase Assay
System Protocol (Promega) using a Lumat LB96P lumi-
nometer (Berthold, Bad Wildbad, Germany).
Results
Mutation analysis
We identified a novel heterozygous mutation in exon 9 of
TBX5 (c.1333delC, p.H445fsX136) in the index patient,
but not in his parents. The de novo deletion of the cytosine
residue at cDNA position 1333 (codon 445) is predicted
to result in a translational frameshift creating not a trun-
cated but an elongated TBX5 protein of 580 amino acids
due to a downstream shift of the termination codon to
position 581 (normal codon position 519). Thus, the
mutant TBX5 protein would contain 74 miscoding amino
acids (positions 445 to 518) and 62 supernumerary C-ter-
minal amino acids [see Additional file 1]. These findings
suggested a de novo mutational event, which most likely
The patient Figure 1
The patient. The patient presents bilateral hypoplastic clavicles and radii (A and C) and bilateral triphalangeal thumbs (B). 
Bradycardia due to atrioventricular block necessitates a pacemaker.BMC Medical Genetics 2008, 9:88 http://www.biomedcentral.com/1471-2350/9/88
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caused Holt-Oram syndrome in our patient. To provide
evidence for the pathogenic effect of this special mutation,
we carried out further functional investigations.
c.1333delC does not influence intracellular localization
The entire coding sequence of human wild type and
mutated TBX5 was cloned into the GFP expression plas-
mid pEGFP-N3, whereas the coding sequence of SALL4
was inserted into the FLAG expression plasmid pFLAG-
N3, resulting in TBX5wt-GFP, TBX5mut-GFP and SALL4-
FLAG fusion proteins. TBX5 was shown to display a
nuclear localization during embryogenesis, thereby hav-
ing two distinct nuclear localization signals working
cooperatively [17,19]. The murine homologue of SALL4 is
a nuclear protein localized to heterochromatin and oper-
ating as a transcriptional repressor [20]. In the mouse,
Sall4 and Tbx5 colocalize and interact physically [14].
In order to analyze the mutated TBX5 protein for possible
impaired nuclear localization we transfected COS-7 cells
with TBX5-GFP wild type or mutant constructs and ana-
lyzed the intracellular distribution of the proteins by use
of confocal laser scanning microscopy (CLSM, Fig. 2). The
distribution of TBX5 wild type (Fig. 2A) and mutant pro-
teins (Fig. 2B) both appeared as dot-like structures in the
nucleus. Transfection of the empty GFP vector was used as
negative control, and resulted in a diffuse nuclear staining
(Fig. 2C). To assess whether the intranuclear distribution
of mutated TBX5 differs from the wild type protein, we co-
transfected COS-7 cells with SALL4 and either wild type or
mutated TBX5 constructs. SALL4 was detected by use of
mouse anti-FLAG antibody and goat anti-mouse IgG-
TRITC. An overlay of the SALL4 and TBX5 wild type (Fig.
3A, 3B, 3C) and mutant signals (Fig. 3D, 3E, 3F) demon-
strated co-localization of both proteins, respectively.
Thus, the mutation c.1333delC does not affect the trans-
port of the protein to the nucleus nor its intranuclear dis-
tribution.
c.1333delC mutation impairs activation of the ANF 
promoter
An important functional domain of TBX5 is the T-box
motif involved in DNA-binding and protein-protein inter-
actions [10,11]. The majority of the described TBX5 muta-
tions result in preterminal stop codons. The functional
effect of the c.1333delC mutation – leading to an elon-
gated protein – on transcriptional regulation was assessed
using a luciferase assay. COS-7 cells were transiently co-
transfected with mutant/wild type TBX5 expression con-
structs (pFLAG-N3) and an ANF-luciferase construct as
reporter. The upstream region of the ANF (atrial natriu-
retic factor gene) promoter contains a TBX5 binding site
[21]. The luciferase activity was normalized in reference to
the Renilla reniformis luciferase activity, used as an internal
control. The constructs were analyzed by immunoblot for
appropriate expression (data not shown). Reporter gene
activation significantly increased in cells transfected with
wild type TBX5  compared to cells transfected with the
empty expression vector. Transfection of the TBX5-GFP
construct lead to the same result, indicating that neither
the FLAG-tag nor the GFP-tag (as used in the localization
studies) have a detrimental effect on the protein function.
The luciferase activity of the mutated TBX5-FLAG con-
struct was strongly reduced to a value comparable to cells
Intracellular localization of wild type and mutant TBX5 Figure 2
Intracellular localization of wild type and mutant TBX5. (A) COS-7 cells were transfected with TBX5 fused to the 
sequence encoding the green fluorescent protein (GFP). Wild type TBX5 appeared in dot-like structures in the nuclei (blue, 
stained with DAPI) of the analyzed cells. (B) The mutant TBX5 displays a distinct and homogenous arrangement in the nucleus, 
the distribution pattern does not differ compared to the wild type TBX5. (C) The empty pEGFP-N3-vector was transfected as 
a negative control and resulted in a diffuse nuclear staining.BMC Medical Genetics 2008, 9:88 http://www.biomedcentral.com/1471-2350/9/88
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transfected with the empty pFLAG-N3 vector. An
increased amount of transfected TBX5mut plasmid (300
ng, 450 ng, 600 ng) did not induce luciferase activity, rul-
ing out a dosage effect (Fig. 4). Under the experimental
conditions of cell culture mediated luciferase assays, the
mutation c.1333delC abrogates activation of the ANF pro-
moter by TBX5.
Discussion
Autosomal dominant Holt-Oram syndrome, linked to
mutations in the T-box transcription factor gene TBX5, is
characterized by bilateral forelimb malformations and
congenital heart defects. Also defects of the pulmonary
veins are common. Mutations found in TBX5 include mis-
sense, nonsense, frameshift and splice site mutations as
well as large deletions (TBX5  gene mutation database;
http://www.uni-leipzig.de/~genetik/TBX5) [4,6,22].
Mutations in the N-terminal region of the T-box affect
binding of TBX5 to the major groove of DNA, while muta-
tions in the C-terminal region of the T-box affect binding
to the minor grove. There is no obvious genotype-pheno-
type correlation. The severity of limb and heart varies
independently of type and location of the mutation [23].
Diverse known TBX5  missense mutations (p.Q49K,
p.I54T, p.G80R, p.G169R, p.R237Q, p.R237W, and
p.S252I) reduce synergistic transcriptional activity of the
downstream target ANF, but only the mutations p.G80R,
p.R237Q, and p.R237W were shown to affect DNA-bind-
ing [13]. In addition, an impaired nuclear localization of
the altered proteins was demonstrated. Similar results
were obtained by functional analysis of the in-frame
mutation 381-408del (c.376_402del, p.K126_R134del)
[13]. To assess a putative functional effect of the de novo
c.1333delC (p.H445fsX136) mutation on transcriptional
activation we co-transfected COS-7 cells with mutant/
wild type TBX5 expression constructs and an ANF-luci-
Co-localization of wild type and mutant TBX5 with SALL4 Figure 3
Co-localization of wild type and mutant TBX5 with SALL4. The subcellular distribution of the proteins was analyzed in 
COS-7 cells transfected with either wild type or mutant TBX5-GFP constructs and SALL4-FLAG. SALL4 was detected using 
mouse α-FLAG antiserum and a secondary goat anti-mouse TRITC-labelled antibody. SALL4 and TBX5 (A, B, C) form overlap-
ping distinct structures in the nucleus. The SALL4 signal was also shown to interfere with subcellular distribution of the 
mutated TBX5 in dot-like structures in the nucleus (D, E, F). The nuclei, stained with DAPI, appear in blue.BMC Medical Genetics 2008, 9:88 http://www.biomedcentral.com/1471-2350/9/88
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ferase construct. Under the experimental conditions of the
luciferase assay, the reporter gene activation through the
mutated TBX5 protein was abrogated and non functional
as compared to the wild type protein.
The human TBX5 gene consists of 8 coding exons and one
5' non-coding exon dispersed over 53 kilobases (kb) on
chromosome 12q24. Proteins of the T-box family com-
prise two distinct structural and functional domains: the
DNA-binding domain, referred as T-box, and a transcrip-
tional activator or repressor domain [24]. Residues of the
T-box are highly conserved throughout members of this
family and across species. Binding-site selection experi-
ments showed an affinity of T-box proteins for the con-
sensus sequence TCACACCT [25]. The transcriptional
regulation activity was shown to require sequence motifs
within the C-terminal part of the protein [25]. For the
development of specific organs like heart and upper
limbs, TBX5 is an essential transcription factor. The
import to the nucleus is thereby promoted by two distinct
nuclear localization signals (NLS) working in concert. The
two minimal sequences required for nuclear import were
found to reside within (aa 79–90) and carboxyl to the T-
box (325–340). The first amino acid affected by the muta-
tion c.1333delC (His445) is carboxyterminal of both
regions required for nuclear localization. This mutation
resides within the last exon, we therefore assume, that the
TBX5 mRNA bearing the single nucleotide deletion is not
degraded by nonsense mediated decay. This mechanism
was shown to occur only in case that the preterminal stop
codon is located at least 50–55 nucleotides before the last
exon/exon boundary [26]. Thus, messenger RNAs with
nonsense mutations or small deletions/insertions in the
last exon are generally translated into a protein. As the
patient's deletion was detected in the last exon of TBX5,
the mRNA is predicted to result in a elongated protein
consisting of 580 instead of 518 amino acids. It is conceiv-
able that an altered protein configuration or steric hin-
drance may silence the activity of the NLS motifs. We
therefore wanted to analyze the intracellular distribution
of the mutated TBX5 protein. TBX5 is mainly expressed
during embryonic morphogenesis and is limited to
esophagus, heart, liver, lung, prostate and trachea in the
adult organism. Blood samples from the patient were
taken for DNA sequence analysis, but could not be used
for investigations on the TBX5 protein as it is not detecta-
ble in lymphocytes. Consequently we did not have the
possibility to analyze the presence and the intracellular
localization of the endogenous elongated protein. Other
possible TBX5 sources were not available. All experiments
were therefore carried out by transfecting wild type and
mutated fusion constructs into an appropriate cell line.
Both wild type as well as mutated TBX5 proteins were
found to localize in dot-like structures within the nucleus,
and both co-localize with SALL4. The murine homologue
Sall4 was previously demonstrated to localize to hetero-
chromatin and to operate as a transcriptional repressor
[20].
Conclusion
Interestingly, four other truncating mutations have been
detected in exon 9 of the TBX5  gene (c.1024delT,
c.1084C>T, c.1159dupA, c.1366C>T) so far to our knowl-
edge. All result in shortening of the TBX5 protein. How-
ever, it is unclear how those lead to TBX5
haploinsufficiency, since the mutations will most likely
not lead to nonsense-mediated mRNA decay, because
they reside within the most 3' positioned exon. The
unique mutation c.1333delC differs from the other muta-
tions in exon 9 as it leads to an elongated protein. Since
the mutation neither affects the intranuclear distribution
of TBX5 nor its colocalization with SALL4, but abrogates
activation of the ANF promoter, it is tempting to speculate
that the supernumerary amino acids modulate the config-
uration of the protein by masking the transcriptional acti-
vator domain.
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Functional effect of the TBX5 c.1333delC mutation on tran- scriptional regulation Figure 4
Functional effect of the TBX5 c.1333delC mutation 
on transcriptional regulation. COS-7 cells were tran-
siently co-transfected either with mutant or wild type TBX5 
expression constructs and a reporter encoding the luciferase 
gene under the control of the ANF promoter. Values were 
calculated by normalizing against Renilla reniformis luciferase 
activity and compared to the empty FLAG vector (column 1). 
Wild type TBX5-FLAG and TBX5-GFP effectively induced 
expression of the reporter gene (columns 2 and 3), whereas 
cells transfected with rising amounts of the mutant TBX5 
construct demonstrated entire abrogation of reporter gene 
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